Renshen Jingye Zongzao Gan Jiaonang (人参茎叶总皂苷胶囊)人参茎叶总皂苷胶囊
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 青海夏都医药有限公司Chinese legal name: 青海夏都医药有限公司
主要成分Active Ingredients
- 人参总皂苷Renshen Zongzao Gan
药物知识说明
人参总皂苷是一种在国家药监局注册认定的药品。该药品含有人参总皂苷-31f6ef1e等成分。
该药品关联的活性成分包括：人参总皂苷Renshen Zongzao Gan。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：青海夏都医药有限公司Chinese legal name: 青海夏都医药有限公司。
您可以探索含有相同成分的其他药品：人参总皂苷-31f6ef1e成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 人参茎叶总皂苷胶囊) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 人参总皂苷Renshen Zongzao Gan.
Manufacturers recorded for this product: 青海夏都医药有限公司Chinese legal name: 青海夏都医药有限公司.
Explore other medicines containing the same ingredient: 人参总皂苷 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 人参茎叶总皂苷胶囊Recorded Chinese name: 人参茎叶总皂苷胶囊
- 剂型Dosage form: 胶囊剂Capsules
- 规格Specification: 25mg25 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 青海夏都医药有限公司Chinese legal name: 青海夏都医药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H63020222
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H63020222
Manufacturer
Chinese legal name: 青海夏都医药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Keep sealed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H63020222
生产企业
青海夏都医药有限公司(国产)
适应症
用于冠心病，更年期综合征，隐性糖尿病及肿瘤的辅助用药。
用法用量
口服，一次1～2粒，一日3次。
不良反应
长期或大量使用，可致失眼、欣快、心悸、血压升高，少数人表现抑郁。可能出现头痛、神经过敏、激动和睡眠困难。如果上述症状持续存在或加重，应告诉医生。很少出现腹泻、心跳过快或不规则、皮疹或阴道异常流血，一旦出现应立即告诉医生。除此之外，如果您还发现了其它不良反应，应跟医生或药师联系。
禁忌
对本品过敏者禁用。
注意事项
1.忌辛辣、生冷、油腻食物。
2.感冒发热病人不宜服用。
3.本品宜饭前服用。
4.高血压、心脏病、糖尿病、肝病、肾病等慢性病患者应在医师指导下服用。
5.儿童、孕妇应在医师指导下服用。
6.服药2周症状无缓解，应去医院就诊。
7.对本品过敏者禁用，过敏体质者慎用。
8.药品性状发生改变时禁止服用。
9.儿童必须在成人监护下使用。
10.请将此药品放在儿童不能接触的地方。
11.如正在服用其他药品，使用本品前请咨询医师或药师。
贮藏
密封。
规格
25mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.